Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
letter
. 1966 Apr 16;1(5493):960–961.

Liver Damage from Oral Contraceptives

Basil A Stoll, J T Andrews, R Motteram
PMCID: PMC1844899

Full text

PDF
960

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKKE J. L. HEPATIC IMPAIRMENT DURING INTAKE OF CONTRACEPTIVE PILLS: OBSERVATIONS IN POST-MENOPAUSAL WOMEN. Br Med J. 1965 Mar 6;1(5435):631–632. doi: 10.1136/bmj.1.5435.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BORGLIN N. E. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1965 May 15;1(5445):1289–1290. doi: 10.1136/bmj.1.5445.1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRAIN, PARKES A. S., BISHOP P. M. SOME MEDICAL ASPECTS OF ORAL CONTRACEPTIVES. Lancet. 1964 Dec 19;2(7373):1329–1332. doi: 10.1016/s0140-6736(64)91120-1. [DOI] [PubMed] [Google Scholar]
  4. CORBETT H. V. ORAL CONTRACEPTION AND LIVER DAMAGE. Br Med J. 1964 Nov 14;2(5419):1264–1265. [PMC free article] [PubMed] [Google Scholar]
  5. CULLBERG G., LUNDSTROEM R., STENRAM U. JAUNDICE DURING TREATMENT WITH AN ORAL CONTRACEPTIVE, LYNDIOL. Br Med J. 1965 Mar 13;1(5436):695–697. doi: 10.1136/bmj.1.5436.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. EISALO A., JAERVINEN P. A., LUUKKAINEN T. HEPATIC IMPAIRMENT DURING THE INTAKE OF CONTRACEPTIVE PILLS: CLINICAL TRIAL WITH POSTMENOPAUSAL WOMEN. Br Med J. 1964 Aug 15;2(5406):426–427. doi: 10.1136/bmj.2.5406.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. EISALO A., JAERVINEN P. A., LUUKKAINEN T. LIVER-FUNCTION TESTS DURING INTAKE OF CONTRACEPTIVE TABLETS IN PRE-MENOPAUSAL WOMEN. Br Med J. 1965 May 29;1(5447):1416–1417. doi: 10.1136/bmj.1.5447.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LARSSON-COHN U. ORAL CONTRACEPTION AND LIVER-FUNCTION TESTS. Br Med J. 1965 May 29;1(5447):1414–1415. doi: 10.1136/bmj.1.5447.1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LINTHORST G. LIVER FUNCTION AFTER LONG-TERM PROGESTATIONAL TREATMENT WITH AND WITHOUT OESTROGEN. Br Med J. 1964 Oct 10;2(5414):920–921. doi: 10.1136/bmj.2.5414.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PALVA I. P., MUSTALA O. O. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Sep 12;2(5410):688–689. doi: 10.1136/bmj.2.5410.688-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RICE-WRAY E. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Oct 17;2(5415):1011–1011. doi: 10.1136/bmj.2.5415.1011-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SCHAFFNER F., POPPER H., CHESROW E. Cholestasis produced by the administration of norethandrolone. Am J Med. 1959 Feb;26(2):249–254. doi: 10.1016/0002-9343(59)90314-6. [DOI] [PubMed] [Google Scholar]
  14. STOLL B. A., ANDREWS J. T., MOTTERAM R., UPFILL J. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1965 Mar 13;1(5436):723–723. doi: 10.1136/bmj.1.5436.723-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SWYER G. I., LITTLE V. ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS. Br Med J. 1965 May 29;1(5447):1412–1414. doi: 10.1136/bmj.1.5447.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES